BNP Paribas Financial Markets’s KalVista Pharmaceuticals KALV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $45.7K | Buy |
|
|||||
|
2025
Q1 | $31.7K | Sell |
|
|||||
|
2024
Q4 | $53K | Sell |
|
|||||
|
2024
Q3 | $501K | Buy |
|
|||||
|
2024
Q2 | $35.5K | Sell |
|
|||||
|
2024
Q1 | $214K | Buy |
|
|||||
|
2023
Q4 | $113K | Buy |
|
|||||
|
2023
Q3 | $35.5K | Sell |
|
|||||
|
2023
Q2 | $115K | Buy |
|
|||||
|
2023
Q1 | $93.7K | Buy |
|
|||||
|
2022
Q4 | $41.3K | Sell |
|
|||||
|
2022
Q3 | $105K | Buy |
|
|||||
|
2022
Q2 | $58.6K | Buy |
|
|||||
|
2022
Q1 | $26.1K | Sell |
|
|||||
|
2021
Q4 | $63.1K | Buy |
|
|||||
|
2021
Q3 | $62.8K | Buy |
|
|||||
|
2021
Q2 | $18.4K | Sell |
|
|||||
|
2021
Q1 | $215K | Buy |
|
|||||
|
2020
Q4 | $56.2K | Sell |
|
|||||
|
2020
Q3 | $44.5K | Buy |
|
|||||
|
2020
Q2 | $13.9K | Sell |
|
|||||
|
2020
Q1 | $35.2K | Buy |
|
|||||
|
2019
Q4 | $32.1K | Buy |
|
|||||
|
2019
Q3 | $17.1K | Buy |
|
|||||
|
2019
Q2 | $1.51K | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $10.2K | Buy |
|
|||||
|
2015
Q3 | $9.86K | Buy |
|